NRGene Technologies Ltd. Logo

NRGene Technologies Ltd.

AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.

NRGN | TA

Overview

Corporate Details

ISIN(s):
IL0011720716
LEI:
Country:
Israel
Address:
5 Golda Meir Street, 7403649 Ness Ziona
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NRGene Technologies Ltd. is an agricultural technology (AgTech) company that develops and commercializes artificial intelligence-based software and genomic analysis tools. The company provides turn-key solutions that analyze large-scale genomic data to accelerate and optimize natural breeding processes for plants and animals. Its proprietary algorithms and platforms are utilized by leading breeding companies, seed developers, and agricultural organizations to enhance crop and livestock development, discover novel genetic traits, and improve food production sustainability. NRGene's core offerings include comprehensive genotyping solutions and genomic big data analytics designed to reveal genetic complexity and diversity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-09 20:13
Regulatory News Service
Following the completion of its contracted two-year engagement under the Tel Av…
Hebrew (modern) 174.5 KB
2023-08-09 20:13
Business and Financial Review
Following the completion of its contracted two-year engagement under the Tel Av…
Russian 46.0 KB
2023-05-22 23:48
Management Discussion and Analysis
Analysis update report, target price remains 19.8 NIS
English 969.2 KB
2023-05-22 23:48
Earnings Release
Analysis update report, target price remains 19.8 NIS
Russian 70.9 KB
2023-04-13 20:31
Earnings Release
Analysis update - target price t is updated to NIS 19.8
English 959.3 KB
2023-04-13 20:31
Regulatory News Service
Analysis update - target price t is updated to NIS 19.8
Russian 67.3 KB
2022-12-11 20:51
Business and Financial Review
Analysis update report, target price remains 30.9NIS
English 1.1 MB
2022-12-11 20:51
Report Publication Announcement
Analysis update report, target price remains 30.9NIS
Russian 64.0 KB
2022-09-13 22:01
Investor Presentation
update Analysis (FROST) following financial report, target price remains NIS 30…
English 1.2 MB
2022-09-13 22:01
Report Publication Announcement
update Analysis (FROST) following financial report, target price remains NIS 30…
Russian 60.5 KB
2022-08-15 21:22
Investor Presentation
Investors Presentation - August 2022
English 2.5 MB
2022-08-15 21:22
Report Publication Announcement
Investors Presentation - August 2022
Russian 41.9 KB
2022-05-31 21:47
Investor Presentation
Analysis update report, target price remains 30.9NIS
English 1.1 MB
2022-05-31 21:47
Report Publication Announcement
Analysis update report, target price remains 30.9NIS
Russian 55.2 KB
2022-04-03 22:30
Regulatory News Service
Quarterly analysis update report, target price remains 30.9NIS
English 1.1 MB

Automate Your Workflow. Get a real-time feed of all NRGene Technologies Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NRGene Technologies Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NRGene Technologies Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan 7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.